NVLN Insider Trading Activity and SEC Form 4 Filings
NVLN insider trading summary
No open-market insider purchases or sales of Novelion Therapeutics Inc. (NVLN) have been reported on SEC Form 4 in the past 12 months.
Latest NVLN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 27, 2018 | Broadfin Capital, LLC | 10% Owner | Sell | $85K (100,000 @ $0.85) |
| Dec 27, 2018 | Kevin Kotler | 10% Owner | Sell | $85K (100,000 @ $0.85) |
| Dec 27, 2018 | Broadfin Capital, LLC | 10% Owner | Sell | $13K (14,800 @ $0.88) |
| Dec 27, 2018 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Sell | $85K (100,000 @ $0.85) |
| Dec 27, 2018 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Sell | $48K (56,316 @ $0.85) |
| Dec 27, 2018 | Broadfin Capital, LLC | 10% Owner | Sell | $48K (56,316 @ $0.85) |
| Dec 27, 2018 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Sell | $13K (14,800 @ $0.88) |
| Dec 27, 2018 | Kevin Kotler | 10% Owner | Sell | $13K (14,800 @ $0.88) |
| Dec 27, 2018 | Kevin Kotler | 10% Owner | Sell | $48K (56,316 @ $0.85) |
| Dec 26, 2018 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Sell | $81K (83,245 @ $0.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.